Total Assets$XTALPI(02228.HK) In January of this year, the FDA received a letter of intent for the liver organ-on-a-chip ISTAND program led by the 3Rs Collaborative. In that long list of participants—Axiom/LifeNet Health, BioIVT, CN Bio, DefiniGEN, TissUse...
Xellar (Yaosu Technology) is the only Chinese organ-on-a-chip company selected. The more you look into this company, the more interesting it gets. As Xie Xin said: In the future, our technology platform is expected to directly enter the IND application system and become a standard tool in the new drug R&D process.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
